Ginkgo Bioworks Holdings, Inc.

US$11.29As of Sun 8 Nov 2026, 12:00 UTC
NYSE:DNAHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (47.80%)
Div yield —
ROE (58.22%)
Biotechnology
Beta (5Y) 1.74
PE TTM —
TSR TTM (13.09%)
Mkt cap US$760.3M
ROIC (18.97%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$13
15.77%
(3.06%)
Hold 2|10|4|6|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.11
0.11
0.12
0.13
(3.28%)
1.96%
9.40%
21.21%
Revenue$M
75.54
76.11
79.64
79.86
12.13%
12.27%
11.14%
8.20%
Peers (US$760.3M)
Cap (US$)
PE
780.5M
—
Capital
TTM
5Y
10Y
Leveragex
0.467
0.616
0.510
EBIT/Intx
12.93
0.052
0.063
Own earn%
526.99
(114.69)
(104.80)
Sh yield%
33.88
25.85
27.36
Owners
Insiders/Inst%
3.99
59.65
Short interest%
3.55
SBC / revenue%
4.34
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
2–11
$1 testx
—
Incr. ROIC%
2